Teladoc Health, Inc. (NYSE:TDOC) Given Average Recommendation of “Hold” by Brokerages

Shares of Teladoc Health, Inc. (NYSE:TDOC) have earned an average recommendation of “Hold” from the twenty-one analysts that are currently covering the stock, Marketbeat.com reports. Fourteen investment analysts have rated the stock with a hold recommendation and seven have issued a buy recommendation on the company. The average 1-year target price among analysts that have issued ratings on the stock in the last year is $12.08.

A number of brokerages have weighed in on TDOC. Barclays increased their price target on Teladoc Health from $10.00 to $12.00 and gave the stock an “overweight” rating in a research note on Thursday, October 31st. Oppenheimer dropped their target price on shares of Teladoc Health from $14.00 to $12.00 and set an “outperform” rating for the company in a research report on Friday. Deutsche Bank Aktiengesellschaft boosted their price objective on shares of Teladoc Health from $10.00 to $12.00 and gave the stock a “hold” rating in a research note on Friday, November 1st. Evercore ISI lifted their target price on shares of Teladoc Health from $8.00 to $9.00 and gave the company an “in-line” rating in a report on Tuesday, October 8th. Finally, Royal Bank of Canada increased their price target on Teladoc Health from $11.00 to $12.00 and gave the company an “outperform” rating in a report on Friday.

Teladoc Health Stock Down 0.8 %

TDOC opened at $10.06 on Monday. The business has a 50 day simple moving average of $10.01 and a 200-day simple moving average of $9.04. Teladoc Health has a 12 month low of $6.76 and a 12 month high of $21.74. The stock has a market capitalization of $1.73 billion, a P/E ratio of -1.74 and a beta of 1.01. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.73 and a quick ratio of 1.69.

Teladoc Health (NYSE:TDOC) last released its quarterly earnings data on Wednesday, October 30th. The health services provider reported ($0.19) EPS for the quarter, topping analysts’ consensus estimates of ($0.29) by $0.10. Teladoc Health had a negative net margin of 37.91% and a negative return on equity of 10.06%. The firm had revenue of $640.51 million for the quarter, compared to the consensus estimate of $630.50 million. On average, equities analysts anticipate that Teladoc Health will post -1.16 earnings per share for the current fiscal year.

Insider Buying and Selling

In other news, insider Carlos Nueno sold 2,389 shares of the firm’s stock in a transaction on Monday, December 2nd. The stock was sold at an average price of $11.93, for a total transaction of $28,500.77. Following the transaction, the insider now directly owns 2,890 shares of the company’s stock, valued at approximately $34,477.70. This trade represents a 45.25 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. 0.95% of the stock is owned by company insiders.

Hedge Funds Weigh In On Teladoc Health

Hedge funds have recently made changes to their positions in the business. Clearline Capital LP raised its holdings in shares of Teladoc Health by 395.6% during the second quarter. Clearline Capital LP now owns 4,364,201 shares of the health services provider’s stock worth $42,682,000 after acquiring an additional 3,483,665 shares in the last quarter. Point72 Asset Management L.P. lifted its position in shares of Teladoc Health by 57.8% during the 3rd quarter. Point72 Asset Management L.P. now owns 8,366,295 shares of the health services provider’s stock worth $76,803,000 after purchasing an additional 3,063,172 shares during the last quarter. Assenagon Asset Management S.A. acquired a new stake in shares of Teladoc Health in the third quarter worth $15,801,000. Maple Rock Capital Partners Inc. bought a new position in shares of Teladoc Health during the 3rd quarter worth about $11,291,000. Finally, Invenomic Capital Management LP raised its holdings in Teladoc Health by 155.2% in the 3rd quarter. Invenomic Capital Management LP now owns 1,474,337 shares of the health services provider’s stock valued at $13,534,000 after acquiring an additional 896,552 shares in the last quarter. Institutional investors and hedge funds own 76.82% of the company’s stock.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.